| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/17/2004 | CN1481846A Anti-age instant formulation |
| 03/17/2004 | CN1481845A Anti-age glue pill |
| 03/17/2004 | CN1481844A Anti-age honeydewed pill |
| 03/17/2004 | CN1481843A Anti-age tablet formulation |
| 03/17/2004 | CN1481842A Anti-age liquid formulation |
| 03/17/2004 | CN1481827A Extracts of cacao bean and cacao bean husk with inhibitory effects on carcinogenesis |
| 03/17/2004 | CN1481811A Preparation of sodium polyacrylic acid, carboxymethyl cellulose grafted polyacrylic acid as hemostat |
| 03/17/2004 | CN1142178C Novel peptides and remedy for bone diseases contg. same as active ingredient |
| 03/17/2004 | CN1142161C Dihydrobenzodioxine carboxamide and ketone derivatives as 5-HT4 receptor antagonists |
| 03/17/2004 | CN1142153C Benzoylpyridazines |
| 03/17/2004 | CN1142144C 4-phenyl pyridine derivatives |
| 03/17/2004 | CN1141952C Medicine for curing shaoyang disease and its preparing method |
| 03/17/2004 | CN1141942C Health-care polypeptide product of nerve and its preparing process |
| 03/17/2004 | CN1141937C Pharmaceutical composition containing tramadol for preparing medicine of curing hemicrania and the like |
| 03/17/2004 | CN1141936C Usage of aryl-cyclohexylamine derivative in anti-disorder of central nervous system |
| 03/16/2004 | US6706878 Spiroazabicyclic heterocyclic compounds |
| 03/16/2004 | US6706873 Nucleic acid molecule encoding specified amino acid sequence |
| 03/16/2004 | US6706763 Agonistic drug on human peroxisome proliferator-activated receptor (ppar) |
| 03/16/2004 | US6706753 Integrin receptor inhibitors |
| 03/16/2004 | US6706751 Dihydroindole and tetrahydroquinoline derivatives |
| 03/16/2004 | US6706750 Useful in treating obesity and other disorders |
| 03/16/2004 | US6706749 Substituted phenyl derivatives, their preparation and use |
| 03/16/2004 | US6706741 Acetylcholinesterase inhibitors containing 1-benzyl-pyridinium salts |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/16/2004 | US6706726 Anticholinergics which may be used as medicaments as well as processes for preparing them |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/16/2004 | US6706717 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 03/16/2004 | US6706716 Compounds specific for the human α1d adrenergic receptor and uses thereof |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/16/2004 | US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 03/16/2004 | US6706710 Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 03/16/2004 | US6706709 Treating, for example, proliferative disorders including cancer |
| 03/16/2004 | US6706708 Cytotoxic agents comprising taxanes and their therapeutic use |
| 03/16/2004 | US6706707 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 03/16/2004 | US6706706 Non-nucleoside reverse transcriptase inhibitors |
| 03/16/2004 | US6706703 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (ige) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/16/2004 | US6706702 For therapy of neurological and psychological disorders |
| 03/16/2004 | US6706689 Administering glucagon like peptide-1 (glp-1), where the patient is not suffering from a q-wave myocardial infarction |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706514 Polypeptides capable of interacting with the human topoisomerase IIIα |
| 03/16/2004 | US6706491 Reagents and methods for identifying and modulating expression of genes regulated by p21 |
| 03/16/2004 | US6706293 Pharmaceutical composition capable of regulating the expression of adhesion molecules |
| 03/16/2004 | US6706266 Oncostatin M antagonists |
| 03/16/2004 | US6706261 Compositions and methods comprising immunogenic muteins of interleukin-6 |
| 03/16/2004 | US6706021 Anticoagulant for catheters, dialysis machines, syringes, tubes, blood lines and stents; trypsin-like serine proteases such as thrombin; 3-benzylsulfonylamino-6-methyl-1-((2-guanidinooxyethyl) aminocarbonylmethyl)-2-pyridinone |
| 03/16/2004 | CA2294399C Farnesyl transferase inhibitors in combination with hmg coa reductase inhibitors for the treatment of cancer |
| 03/16/2004 | CA2223745C Method of solubilizing, purifying, and refolding protein |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/16/2004 | CA2079143C Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/11/2004 | WO2004020462A1 Cxcr4 antagonist and use thereof |
| 03/11/2004 | WO2004020435A1 Piperidinyl compounds that selectively bind integrins |
| 03/11/2004 | WO2004020434A1 Azaarene derivatives |
| 03/11/2004 | WO2004020433A1 Novel crystals |
| 03/11/2004 | WO2004020426A1 Process for the production of an immunosuppressant |
| 03/11/2004 | WO2004020421A1 Novel quaternary ammonium compounds |
| 03/11/2004 | WO2004020407A1 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 03/11/2004 | WO2004020393A1 Dibenzylamine compound and medicinal use thereof |
| 03/11/2004 | WO2004020011A1 Embolization |
| 03/11/2004 | WO2004019999A2 Agent delivery particle |
| 03/11/2004 | WO2004019984A1 Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd |
| 03/11/2004 | WO2004019982A1 Remedy |
| 03/11/2004 | WO2004019981A1 Method of diffrentiation and maturation of non-nerve cells into nerve cells, agent therefor and method of searching for the agent |
| 03/11/2004 | WO2004019968A1 Methods for preserving organs and tissues |
| 03/11/2004 | WO2004019962A1 Hair growth stimulants for oral use |
| 03/11/2004 | WO2004019958A1 Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof |
| 03/11/2004 | WO2004019957A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
| 03/11/2004 | WO2004019955A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 03/11/2004 | WO2004019951A1 REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS |
| 03/11/2004 | WO2004019949A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | WO2004019948A1 New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno[2,3-d]pyrimidine |
| 03/11/2004 | WO2004019946A1 Inhibitors for excessive accumulation of sodium ion in cells |
| 03/11/2004 | WO2004019944A1 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 03/11/2004 | WO2004019941A1 Glycinamide derivatives as raf-kinase inhibitors |
| 03/11/2004 | WO2004019929A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 03/11/2004 | WO2004009578A3 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 03/11/2004 | WO2004002462A3 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
| 03/11/2004 | WO2004000789A9 Amide linker peroxisome proliferator activated receptor modulators |
| 03/11/2004 | WO2003106380A3 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 03/11/2004 | WO2003096782A3 Process for preparing maytansinol |
| 03/11/2004 | WO2003094840A3 Induction of antigen specific immunologic tolerance |
| 03/11/2004 | WO2003092599A3 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent |
| 03/11/2004 | WO2003091264A3 Non nucleoside reverse transcriptase inhibitors |
| 03/11/2004 | WO2003089615A3 Antiviral inhibitions of capsid proteins |
| 03/11/2004 | WO2003088915A3 Novel sodium channel blockers |
| 03/11/2004 | WO2003084342A3 Method and dietary composition for improving lipid digestibility |
| 03/11/2004 | WO2003082861A3 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases |
| 03/11/2004 | WO2003075899A3 Combinations comprising epothilone derivatives and alkylating agents |
| 03/11/2004 | WO2003065789A3 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 03/11/2004 | WO2003063864A3 Heterocyclic compounds which are active as inhibitors of beta lactamases |
| 03/11/2004 | WO2003062247A3 Phosphinic pseudo-peptide derivatives for selective inhibition of the active c-terminal site of angiotensin converting enzyme (i) (ace) |
| 03/11/2004 | WO2003057201A3 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 03/11/2004 | WO2003057133A3 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 03/11/2004 | WO2003054141A3 Sperm-specific cation channel, catsper2, and uses therefor |
| 03/11/2004 | WO2003053945A3 Urea derivatives and their use as vanilloid receptor antagonists |
| 03/11/2004 | WO2003042247A3 Modified anti-tnf alpha antibody |
| 03/11/2004 | WO2003041736A3 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 03/11/2004 | WO2003040337A3 Polyamide modulators of cox2 transcription |